Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that produces a selective loss of the motor neurons of the spinal cord, brain stem and motor cortex. Oxidative stress (OS) associated with mitochondrial dysfunction and the deterioration of the electron transport chain has been shown...

Descripción completa

Detalles Bibliográficos
Autores: Sandra Carrera, Julia, Moreno Sancho, María de la Luz, Barrios Pitarque, Carlos, de la Rubia Ortí, José Enrique, Drehmer Rieger, Eraci
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad Católica de Valencia San Vicente Mártir
Repositorio:RIUCV. Repositorio de la Universidad Católica de Valencia San Vicente Mártir
Idioma:inglés
OAI Identifier:oai:riucv.ucv.es:20.500.12466/3214
Acceso en línea:http://hdl.handle.net/20.500.12466/3214
Access Level:acceso abierto
Palabra clave:Amyotrophic lateral sclerosis
Neurodegenerative diseases
Oxidative stress
Mitochondrial dysfunction
Nicotinamide riboside
Pterostilbene
3207.11 Neuropatología
2411.11 Neurofisiología
Descripción
Sumario:Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that produces a selective loss of the motor neurons of the spinal cord, brain stem and motor cortex. Oxidative stress (OS) associated with mitochondrial dysfunction and the deterioration of the electron transport chain has been shown to be a factor that contributes to neurodegeneration and plays a potential role in the pathogenesis of ALS. The regions of the central nervous system affected have high levels of reactive oxygen species (ROS) and reduced antioxidant defenses. Scientific studies propose treatment with antioxidants to combat the characteristic OS and the regeneration of nicotinamide adenine dinucleotide (NAD+) levels by the use of precursors. This review examines the possible roles of nicotinamide riboside and pterostilbene as therapeutic strategies in ALS.